BridgeBio Pharma, Inc. (BBIO) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$13,978
Total Return
39.78%
CAGR
6.93%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.09% |
| Median | +0.85% |
| Best | +129.58% |
| Worst | -75.68% |
| % of Windows Positive | 52.2% |
1-Year (252 Trading Days)
| Average | +60.81% |
| Median | +59.39% |
| Best | +513.05% |
| Worst | -90.67% |
| % of Windows Positive | 66.2% |
3-Year (756 Trading Days)
| Average | +259.58% |
| Median | +310.48% |
| Best | +1047.14% |
| Worst | -63.57% |
| % of Windows Positive | 64.4% |
Risk Metrics
| Maximum Drawdown | -91.89% |
| Average Drawdown | -50.63% |
| Drawdown Duration | 1084 Trading Days |
| Sortino Ratio | 0.86 |
| Calmar Ratio | 0.08 |
| CVaR (5%) | -9.88% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +1.88% (+6.77% ann.) | +$188.26 | $0.00 | $0.00 | $0.00 |
| 2025 | +178.75% | +$17875.38 | $0.00 | $0.00 | $0.00 |
| 2024 | -32.03% | $3202.88 | $0.00 | $0.00 | $0.00 |
| 2023 | +429.79% | +$42979.02 | $0.00 | $0.00 | $0.00 |
| 2022 | -54.32% | $5431.66 | $0.00 | $0.00 | $0.00 |
| 2021 | -76.54% | $7654.34 | $0.00 | $0.00 | $0.00 |
| 2020 | +102.88% | +$10288.16 | $0.00 | $0.00 | $0.00 |
| 2019 partial | +27.22% (+60.04% ann.) | +$2722.32 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 27, 2019 – February 19, 2020 | +27.66% | +45.69% | +$2765.88 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -30.87% | -98.52% | $3086.60 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +54.53% | +101.44% | +$5453.30 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -5.72% | -5.44% | $572.49 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -79.09% | -81.01% | $7908.64 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +162.83% | +68.43% | +$16283.19 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +200.19% | +101.52% | +$20019.25 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.